ResMed (NYSE:RMD) reported quarterly earnings results on January 29, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of $2.81, beating…
ResMed (NYSE:RMD) reported quarterly earnings results on January 29, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $2.81, beating the consensus estimate of $2.71 by $0.10 per share. Revenue came in at $1.4B, beating the estimate of $1.4B.
ResMed's stock moved following the earnings release. The stock currently trades at $254.74 with a market capitalization of $37.0B.
Current market data
NYSE · RMD
$229.44
Down: -$1.19 · -0.52%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
